Spago Nanomedical AB (publ)
Swedish nanomedicine company developing precision cancer diagnostics and therapy.
Overview
- 10–19
- Employees
- 2.5–5M SEK
- Revenue
- 1999
- Founded
Key Decision Makers
Mats Hansen
Chief Executive Officer (CEO)
Eva Redhe
Nomination Committee Member
Paul Hargreaves
Chief Development Officer (CDO)
Alan Raffensperger
Chairman of the Board
+11 more contacts in Funnelfeedr
Description
Spago Nanomedical AB is a Swedish company currently operating in the clinical development phase. It specializes in precision nanomedicine, utilizing a proprietary platform based on advanced polymeric materials. The core mission is to create more precise treatments and imaging diagnostics for cancer...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556574504801
Decision Makers
15 contacts in FunnelfeedrMats Hansen
Chief Executive Officer (CEO)
Eva Redhe
Nomination Committee Member
Paul Hargreaves
Chief Development Officer (CDO)
Alan Raffensperger
Chairman of the Board
Peter Lindell
Chairman of the Nomination Committee
Kari Grønås
Board Member
Nicklas Westerholm
Board Member
Hanna Olsson
Chief Financial Officer (CFO)
Mikael Lönn
Nomination Committee Member
Mikael von Euler
Board Member
Torsten Malmström
Director CMC & Supply
Other Contacts
Kristian Pietras
Medical Advisor
Sten Nilsson
Medical Advisor
Michael Hofman
Medical Advisor
Austin Smith
Medical Advisor
Similar Companies
20 similar companies in Funnelfeedr
SpectraCure AB (publ)
10–19 employeesDeveloping precise, minimally invasive PDT systems for solid tumor treatment.
ProstaLund AB
10–19 employeesSwedish medtech developing minimal-invasive BPH treatments for men.
BioInvent International Aktiebolag
100–199 employeesClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
BioGaia Pharma AB
0 employeesDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
NUCLITHERA AS
8 employeesDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Browse More
Spago Nanomedical AB (publ) Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo